Global Institute Of Stem Cell Therapy And Research

Stem Cell Revolution Trudges Forward

Stem Cell Revolution Trudges Forward

We are still in the early stages [of stem cell treatment]. In 2014, Dr. Masayo Takahashi and her colleagues at the Riken Center for Developmental Biology had great success using iPS cells to treat macular degeneration.

In some ways, yes, [the promise of stem cells] is overstated. For example, target diseases for cell therapy are limited. There are about 10: Parkinson’s, retinal and corneal diseases, heart and liver failure, diabetes and only a few more — spinal cord injury, joint disorders and some blood disorders…The number of human diseases is enormous.

Stem Cell Revolution Trudges Forward

I think the science has moved too far ahead of talk of ethical issues. When we succeeded in making iPS cells, we thought, wow, we can now overcome ethical issues of using embryos to make stem cell lines.

But soon after, we realized we are making new ethical issues. We can make a human kidney or human pancreas in pigs if human iPS cells are injected into the embryo. But how much can we do those things?

It is very controversial. These treatments may help thousands of people. So getting an ethical consensus is extremely important.

Source : https://goo.gl/1tIykZ

Make An Enquiry

We are here to help you

WordPress Video Lightbox